Crop science giant Bayer says it has settled 17,000 glyphosate cases so far and hopes for a supreme court ruling next year.

Bayer has recently settled thousands of cases over claims the active ingredient in its Roundup weedkiller causes cancer, ...

Heading into the second half of their 2025 financial year, Bayer leaders echo positive comments surrounding the company’s ...

The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...

The company is streamlining its global workforce as part of a multi-year cost-cutting strategy, while raising its 2025 ...

Bayer has applied for approval in the EU of its new herbicide, icafolin, following applications in Brazil, the US, and Canada ...

Bayer on Wednesday said it would be forced to stop its U.S. production of widely-used farming weedkiller glyphosate unless ...

Investor concerns that Bayer's earnings were inflated by soccer player transfer fees rather than supported by its core ...

German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion euros ($1.37 ...

PROFIT FORECAST: The German pharmaceutical and agricultural conglomerate pre-released preliminary second-quarter numbers last week, announcing group earnings before interest, tax, depreciation, ...

Bayer Aktiengesellschaft boosted 2025 sales outlook with pharma growth and lower litigation costs. Click for why BAYRY is an ...

Bayer (BAYRY) stock gains as the company raises 2025 financial outlook, citing strong pharma performance. Read more here.